Skip to main content
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
News article13 May 2024European Medicines Agency1 min read

Draft RWE reflection paper published for public consultation

Five people having a discussion at a table

EMA has published a draft reflection paper on the use of real-world data (RWD) in non-interventional studies to generate real-world evidence (RWE), which discusses methodological and data quality aspects of such studies. The development of this paper is part of the Methodology Working Party Workplan 2022-2024 and the joint HMA-EMA Big Data Steering Group plan 2023-2025.

Interested partners and stakeholders involved in the planning, conduct and analysis of non-interventional studies are invited to provide feedback on the draft reflection paper until 31 August 2024.

The reflection paper will also be presented to gather initial feedback in a dedicated session at the multi-stakeholder joint HMA-EMA workshop on RWE methods on 14 June 2024.

Related information:

Details

Publication date
13 May 2024
Author
European Medicines Agency